Webcast: Sales Agreement with AB Vista

Avivagen’s CEO, Kym Anthony, discusses the recent sales agreement with AB Vista that was announced on Friday, October 1st, 2021. Listen or read the transcript below.   Transcript Operator  Good day ladies and gentlemen. Welcome everyone to Avivagen’s analyst and investor call to discuss their landmark deal with AB Vista. As a reminder, today’s conference […]

Avivagen CEO Interviewed on C-Suite At The Open

TSX At The Open

Kym Anthony, CEO of Avivagen, was recently interviewed by Karoline Hunter, Head of TSX Company Services at the TMX group. The interview covered the company story and gives a look ahead at the future of Avivagen’s OxC-BetaTM. The interview also covers Immune Priming, its powerful anti-inflammatory effect, and its efficacy in improving Gut Health.